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LABORATORY INVESTIGATIONS
Repeated enflurane anaesthetics and model predictions: a study of the 
variability in the predictive performance measures
P. M .  V e rm e u le n ,  J. G. C . L e r o u ,  R . D i r k s e n ,  L .  H .  D . J. B o o i j  a n d  G . F. B o rm
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Summary
We quantified the total variability (reproducibility) 
and the within-patient but between repeat anaes­
thetics variability (repeatability) in measures which 
are used to judge the predictive performance of 
our physiological model. We studied 14 patients 
who received enflurane closed-circuit anaesthesia 
on two occasions. The end-tidal concentrations 
measured and those predicted served to calculate 
the predictive performance measures of the 
model: root mean squared error (rmse=total 
error), bias (systematic error) and scatter (error 
around the bias). The overall results were: rmse 15 
(7) %, bias 0(14)% and scatter 9 (3) % (grand mean 
(total sd)). The within-patient sd values were 
smaller for the rmse (4%) and bias (10%), but not 
for scatter (3%). The repeat rmse values and biases 
were linked to the first results. This implies that 
these performance measures depended partly on 
the patient. As there was no association between 
the personal performance measures and age, sex, 
body weight, body surface area or body mass 
index, these characteristics cannot be used to 
further tune the model. (Br. J. Anaesth. 1997; 79: 
488-496).
patient to predict the concentrations of a drug, 
variability in pharmacokinetic responses must be
J u  A i
taken into account. Until now our clinical studies 
have provided information only on the between- 
patient variability, expressed in terms of variability in 
the predictive performance measures of the model, 
because different patients were studied only once. 
A major unresolved issue was the repeatability of 
the performance measures of the model in a patient 
presenting for repeated anaesthetic procedures.
Therefore, we studied patients who underwent 
enflurane closed-circuit anaesthesia twice. The 
objectives were: to evaluate the extent of correspon­
dence between the predictive performance measures 
of the model obtained in the same patient on two 
occasions under similar clinical conditions; to deter­
mine if these measures varied more among than 
within patients; and to assess the association of the 
performance measures of the model with patient 
characteristics.
Patients and methods
Part of the methods has been described in detail 
previously and is summarized here together with the 
details necessary for this specific study.1 4
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Using average values of physiological variables and 
physicochemical data, we have defined a physio­
logical model for closed-circuit inhalation anaes­
thesia.1 It is capable of predicting end-expired 
concentrations after injection of a liquid anaesthetic 
into a closed-circuit breathing system. Previously we 
have evaluated the predictive performance of the 
model by examining the differences between the 
concentrations predicted and those measured in 
surgical patients. The observed prediction errors
were condensed, per patient, into single
performance measures. These identify the total error 
size (rmse), systematic error (bias) and error around 
the bias (scatter). Close agreement 
predictions and measurements was found in groups 
of patients anaesthetized with different volatile 
anaesthetics.24
Yet, if we wish to apply a model in a particular
PATIENTS AND ANAESTHETIC MANAGEMENT
we a validation study of our
system model enflurane -circuit anaes
thesia in 50 patients. They underwent elective eye 
surgical procedures, and 15 needed a second surgical 
intervention of the same type. After approval of the 
Institutional Ethics and Research Committee, these 
15 consenting, Caucasian patients (ASA I or II) were 
enrolled in the study.
First anaesthetic procedure
Diazepam 5-10 mg and droperidol 2.5-5 mg were 
given orally 1 h before surgery. Anaesthesia was
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induced with fentanyl 0.1-0.2 mg i.v. and a dose of 
thiopentone sufficient to abolish the eyelash reflex. 
Thereafter, vecuronium 0.1 mg kg'1 i.v. was admin­
istered. After placement of a cuffed tracheal tube, 
the lungs of the patients were ventilated artificially 
with a high fresh gas flow of oxygen and nitrous 
oxide in a 1:2 ratio until the end-tidal nitrogen con­
centration was less than 1 vol% or for a maximum of 
5 min. Subsequently, the anaesthetic system was 
closed and closed-circuit anaesthesia commenced. 
The fresh gas flow of oxygen and nitrous oxide was 
adjusted manually to maintain the inspired oxygen 
concentration at 30-40 vol%. The end-tidal carbon 
dioxide concentration was 4.0-5.0 vol%.
Enflurane anaesthesia was administered using the 
liquid injection method by the same 
(P. M. V.). Boluses of liquid enflurane were injected 
into the expiratory limb of the system: one of 0.02 ml 
kg 1 (±0.1 ml) after the start of closed-circuit condi­
tions and repeated increments of 0.01 ml k g 1 during 
maintenance. We did not use a rigid drug regimen, 
but modified enflurane administration to provide 
adequate anaesthesia as in good clinical practice. 
Therefore, we monitored carefully the patient’s 
response to surgery by assessment of non-invasive 
arterial pressure measurement, heart rate and heart 
rate variability judged by ear with the aid of pulse 
oximetry, and also end-tidal enflurane concentra­
tion. Additional i.v. fentanyl 0.05-0.1 mg was given 
according to clinical needs.
This was separated from the first by at least 2 weeks. 
Patients received the same premedication. Anaesthesia 
was induced
the fresh gas flow in order to provide closed-circuit 
conditions mostly necessitated frequent adjustments 
of tidal volume and the flowmeters at the beginning 
of closed-circuit anaesthesia. Five minutes were 
required until we were confident that tidal volume 
was equal during repeated measurements. There­
fore, we only analysed data acquired after this initial
non state
A respiratory mass spectrometer (Centronic 200 
MGA or QP9000; CaSE, 
continuously sampled
mam.
at the Y-piece of the
via a am
port (the sample flow is part of the model)
variation of the mass 
readings was 2%. Before starting each measurement 
we verified calibration of the mass spectrometer for 
enflurane with a calibration gas mixture containing 
1% enflurane in 30% oxygen, 30% nitrous oxide and 
balance gas nitrogen (AGA Gas, Amsterdam, The 
Netherlands).
A personal computer system with a 12-bit 
analogue-to-digital board (Keithley Metrabyte, 
Taunton, MA, USA) processed the signals from the 
mass spectrometer. The data acquisition software 
was developed with the aid of ASYST (Keithley 
Metrabyte). On-line analysis of the respiratory 
waveforms allowed continuous monitoring in the 
operating room of the actual inspired and end- 
expired concentrations of nitrogen, oxygen, carbon 
dioxide, nitrous oxide, argon and enflurane. The 
trends of the inspired and end-expired concentra 
tions of enflurane and oxygen of the last 20 min were
The last end
for each 10-sconcentration
for further data
as
The same parameters for mechanical ventilation (fre­
quency, tidal volume) were used. By design we did not 
aim to replicate the timetable of enflurane injections 
from the first anaesthetic. As in the first anaesthetic 
procedure, individual’s anaesthetic needs under given 
surgical conditions prevailed as necessary.
For both procedures, we noted the times and 
volumes of liauid enflurane, and total
enflurane concentration (vol%).
, we Euv-To evaluate our an
expressed the average measured end-tidal 
and nitrous oxide concentrations as 
MAC corrected for age (mMAC) and 
their sum (i.e. total mMAC).5 Before evaluating 
anaesthetic requirements and calculating 
of prediction, we curtailed one of the two 
per patient, that is the one with the longest 
Thus we considered only repeated observations 
exactly the same duration.
a
THE MODEL AND ITS INPUT
The end-expired concentrations 
compared with those predicted by our system model, 
version C, which does not assume a zero circulation 
time and accounts for non-
in i
of the 
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input was ated by means an
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The anaesthetic equipment consisted of an Ohmeda
Modulus CD WI
USA) with a standing bellows ventilator (Ohmeda 
7850). The delivered tidal volume depends on the
rate of fresh flow into the standing bellows
ventilator.6 Consequently, reducing and adjusting
me Î
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The amount of liquid enflurane per injection was 
converted into millilitres of vapour and supplied to 
the model as if the vapour were added to the anaes­
thetic system over a 60-s interval (i.e. the average 
time period necessary for the enflurane liquid to 
evaporate).
Throughout two, our model generated
the time courses of
enflurane concentrations bj 
simulation program (Meerm 
The
importing
end-expired
a TUTSIM
meas
by
data into
program
below)performance measures of the model
. For each patient and 
anaesthetic procedure we predicted the end-expired 
concentrations by applying our system model.
PREDICTIVE PERFORMANCE MEASURES
Table 1 summarizes the measures which serve to 
determine the predictive performance of our model. 
The prediction error (pe) is the difference between a 
predicted and measured value of enflurane concen­
tration, expressed as a percentage of the measured 
value: pe and squared prediction error (pe2) are 
calculated for each time period of 10 s. These two 
quantities are used to provide the following three 
predictive performance measures.
(1) Root mean squared error (rmse). The mean 
squared error (mse) is the average of the squared 
prediction errors. Rmse is defined as v/mse and is a 
measure of the total error budget for an individual 
patient during one anaesthetic procedure. It is not 
influenced by the sign of the prediction errors and 
can be formulated as being composed of bias and 
scatter (table 1).
(2) Bias, that is the of the prediction
errors for an individual patient, is a measure of the 
systematic component of error. It can be either 
positive or negative, thus indicating over prediction 
or under predictions
(3) Scatter is a measure of the variation of the 
prediction errors around their mean (bias) during 
one procedure.
These three measures were calculated for the first 
and the repeat anaesthetic procedure. Thus per 
patient we had a first and repeat rmse, bias and 
scatter, as illustrated in figure 1.
30 40 50 60 70
Time (min)
Figure 1 Repeated observations from a 22-yr-old female patient 
(weight 67 kg5 height 1.75 m). A: Predicted and measured end-tidal 
enflurane concentrations, and prediction errors obtained during die 
first anaesthetic: one per 10-s period. The observed prediction 
errors were condensed into three predictive performance measures: 
total error size (rmse), systematic error (bias) and error around the 
bias (scatter). These were 29.0%, 26.1%, and 12.8%, respectively.
The same variables as in (a ) obtained during the repeated 
procedure. Rmse, bias and scatter were 22.2 %, 19.4 % and 10.8 
%, respectively. The patient was anaesthetized with 7.0 ml of liquid 
enflurane administered in seven injections on both occasions. The 
vertical broken line shows how the data file with the longest 
duration was curtailed to match die durations of both anaesthetics.
VARIABILITY MEASURES
The measures we used to describe the variability in 
the predictive performance measures were in 
accordance with the recently updated reports of the 
International Organization for Standardization 
ISO-5725, part 1 and 2, for repeated measure­
ments.7 8 Detailed information is given in appendix 2 
and a summary follows. Three variances are 
calculated for each of the three performance 
measures (fig. 2).
(1) Within-patient (or repeatability) variance
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Figure 2 Flow diagram for calculating the predictive performance measures of the model (columns A -li) and their 
variability measures (columns f -g )  from p patients: A: patient number; b: number of anaesthetics; c: predicted (Cp) 
and measured (Cm) end-tidal enflurane concentrations: one per 10-s period; D: prediction error (pe) (%) and squared 
prediction error (pe2): one per 10-s period; li: three predictive performance measures: rmse, bias and scatter, any one 
of these results given byjy with the appropriate subscripts for patient and anaesthetic; i;: mean (JO and standard 
deviation (s) of each performance measure in a patient (mathematical expressions simplified for the particular case of 
two observations); g: grand mean of each of the predictive performance measures (Y), with the within-patient (s2^ ,  
between-patient (s2lt) and total (s2-r) variance.
(s2w) is the average of individual variances. It is an 
indicator of the variation in a predictive performance 
measure within a patient (between repeat anaes­
thetics). The within-patient variability can yield an 
estimate of an expected performance measure for an 
individual from other values obtained in the same 
patient during former anaesthetics (= repeatability).
(2) Between-patient variance (s2B) is an indicator 
of the variation in the patient means around the 
grand mean.
(3) Total (or reproducibility) variance 0>2T) 
combines the within- and between-patient variances: 
it reflects the overall variation in a predictive 
performance measure in the sample population. The 
total variability observed in all patients is the 
variability associated with estimating one of the 
performance measures for a random “unexplored” 
patient from the grand mean (= reproducibility). In 
the clinical environment this is the 
encountered most frequently.
Repeatability, between-patient and
s d  (sdw, sdb, sdt ) were 
the performance measures.
for each of
STATISTICAL METHODOLOGY
Graphical of the data preceded
statistical analysis. An analysis of variance was used 
for the predictive performance measures to calculate 
the components of variance according to Armitage 
and Berry.9 Multiple regression analysis was used to 
study the association of age, sex, body weight, body 
mass index (BMI=weight height-2) and body 
surface area (BSA, formula of DuBois and DuBois) 
with the average of the two repeated performance 
measures obtained per patient. The criterion for
rejection of 
(two-sided).
null was P <  0.05
Results
Initially, we studied 15 patients but data from one 
patient (original subject No. 10) were excluded from 
analysis. This patient had an extreme oculocardiac
during the ophthalmic
requiring intervention. The clearly dissimilar clinical
vs
rmse (8.44 vs 38.29%)
.03%) scatter (7.83
a mei
bias (3.14 vs 
vs 12.95%), 
Thus results nine nu
analysed: mean age, body weight, BMI and BSA 
were 37.9 (range 14-66) yr, 71.8 (sd 10.4) kg, 22.6 
(2.7) kg m 2 and 1.89 (0.15) m2, respectively. Mean
Table 2 Details of the closed-circuit conditions and predictive performance measures (mean (sn)). n- 14 for the
first and repeat anaesthetic; n— 28 for the grand mean results (third column). Total mMAC sum of the average 
measured end-tidal enflurane and nitrous oxide concentrations, expressed as multiples of MAC corrected for age*5
m r m m n m  w w w  w im ir
No. of injections
Injections per hour
Volume of liquid enflurane (ml)
Volume of liquid enflurane per hour (ml) 
Average measured end-tidal enflurane (vol%) 
Total mMAC 
Rmse (%)
Bias (%)
Scatter (%)
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1.09 (0.13)
14.63 (7.43) 
-1.77 (13.23) 
9.47 (3.29)
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7.0 (1.2)
7.4 (1.0) 
0.93 (0.14)
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15.75 (6.76)
1.65 (15.08) 
8.53 (2.09)
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duration of closed-circuit anaesthesia was 57.5 
(12.9) min. Altogether these patients provided 9654 
samples of intraoperative data and they were anaes­
thetized with a total of 19 8 ml of liquid enflurane for 
more than 27 h. Details on the repetitive closed- 
circuit conditions, recorded in table 2, corroborate 
that the closed-circuit conditions during both anaes­
thetics matched well. Only minor differences in the 
time schedules of the enflurane bolus injections were 
found. Table 2 also lists the predictive performance 
measures obtained from the first and repeat anaes­
thetic, and from the pooled data. The results from 
the latter data were: rmse 15 (7) %, bias 0 (14) % 
and scatter 9 (3) % (grand mean (sdt )).
GRAPHICAL ANALYSIS
Simple scattergrams can be used to illustrate 
the association between the first and repeated 
observation on each of the performance measures.
(1) Figure 3a (left) demonstrates good agreement 
between repeated observations for total error size. 
Visual assessment of the extent of agreement 
between the two results is aided by the line of 
identity and a zone where the repeated observations 
differ by no more than ±5%. The maximum 
difference is approximately 11% (patient No. 12). 
Figure 3a (right) illustrates that the within-patient 
repeatability is not associated with the size of the
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Figure 3 Left: scattergrams of the repeat vs first observations on each of the performance measures: A: rmse (total 
error budget); u: bias (systematic component of performance error); and c: scatter (error around the bias). Broken 
™ lines of identity, while fu ll lines enclose a zone where the two observations differ by no more than ±5 % for 
rmse values^ ±11% for biases and ±3% for scatters. Right: re-plotted data and lines from the scattergrams on the 
left, showing the differences between the repeated observations (first —repeat) vs the averages per patient for rmse 
values (a), biases (b) and scatters (c). A and the thick lines on the abscissae represent the overall results: rmse 15 (7) 
%, bias 0 (1 4 ) % and scatter 9 (3) % (grand mean (sdt )).
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measurements as there is no relationship between 
the differences in repeated observations and 
averaged individual rmse values.
(2) Figure 3 b (left) provides the two sets of 
systematic errors plotted against each other. The 
difference between the first and repeat bias is not 
greater than 11% for most patients (three patients 
are situated out of this zone). The greatest disparity 
in bias between repeated observations is —15 vs 25%  
(patient No. 12). Again, there is no relationship 
between the differences in repeated observations and 
averaged individual biases, as depicted in figure 3 b 
(right).
(3) Figure 3 c (left and right) that
scatters, although showing agreement to within ±3%> 
for 11 patients, are heavily dispersed in a cloud with­
out a clear link between the repeated observations.
3 it isFrom the right-hand graphs in
F-direction than in
of observations
: X-direction i 3a
(right) and, apart from patient No. 12, also in figure 
3b (right) but not in figure 3c (right).
ANALYSIS OF VARIANCE
Table 3 summarizes the key results of the variability 
in the three predictive performance measures. For 
rmse, the total variance s2T was nearly four-fold the 
within-patient variance ¿'2W, thus s2w was much 
smaller than s2 B. The ratio s d t / s d w was 1.98. For 
bias, 52t  was twice as large as <rw , s2 w was similar 
to s2b , and the ratio s d t / s d w was 1.39. For scatter,
0
ò was not much different from .2W c *
much larger than and the ratio s d t/ s d w was 
1.05.
Table 3 Variability in the predictive performance measures of 
the model obtained in 14 patients who received an enilurane 
anaesthetic twice. ,rw=within-patient but between repeat 
anaesthetics (i.e. repeatability ) variance, = between-patient 
variance, .v2T'~total (i.e. reproducibility ) variance,
SDW= repeatability standard deviation, snB--- betvveen-patient
standard deviation, sn r~ reproducibility standard deviation7 H
Rmse Bias Scatter
Minimum (%) 6.73 26.66 5.89
Maximum (%) 20.07 26.12 17.46
..2^ vv t /o ) 12.80 102.64 6.85
.r  ^ (%~) 37.45 97.68 0.74
s \  (%2) 50.24 200.32 7.59
SDW (% ) 3.58 10.13 2.62
s d h (%) 6.12 9.88 0.86
SI>v (%) 7.09 14.10 2.75
Discussion
We have found that there was a link between the first 
and repeated measurement of the performance of 
the model. This was so for the measures rmse (total 
error size) and bias (systematic error), but not for 
scatter (fig. 3). This finding implies that most 
patients behaved similarly during both anaesthetics.
RATIONALE FOR A MODEL AND ITS VALIDATION
Our results are part of the necessary validation of 
a model. System models are used for 
anaesthetic management, educational applications, 
research development, and to address economic or 
ecological issues. A physiological model is useful in a 
variety of “what happens i f ’ scenarios, for example 
by predicting the effects of physiological perturba­
tions on drug distribution.10 Such a model is based 
on numerous simplifying assumptions, for example 
average values of physicochemical data and physio­
logical variables are used. The disposition of a drug 
in any subject, however, is only predictable within 
limits as a result of variability in pharmacokinetics 
and pharmacodynamics.11-15 It is critically important 
to know the impact of this variability on the 
imprecision and reliability of model-based predic­
tions because far-reaching conclusions can be drawn 
from model behaviour. The variability we wished to 
study was reflected in the variation in the predictive 
performance measures of the model.
Our overall estimates of performance 
were in accordance with 
those found in a former validation study.1 Standards 
to judge the validity of a system model for volatile
defined previously.4 We
of
and measured 
concentrations.71(117 A valid model should not under
anaesthetics have 
focused on the trueness, that is the 
agreement
or over way.
Although it is reasonable to expect a degree of bias 
for each patient on each occasion, the group bias 
should approximate zero. This study yielded a group 
bias of 0 (14 ) % (grand mean (s d t ) ) . In addition, the 
total error size, assessed in terms of rmse, should be 
acceptable for most patients. Relying on biological 
variability in uptake found by several authors, we 
proposed that the total error size of a physiological 
model with zero group bias is acceptable if the rmse 
value of at least 68% of the subjects is <30 %.' 
In this study rmse was <30°/« for the 28
4
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measurements
the
MULTIPLE REGRESSION ANALYSIS
The average of the two 
obtained per individual, representing 
estimate of a “personal” result for each patient (e.g. 
a personal rmse or bias), was used to assess the 
potential influence of anthropometric patient 
characteristics on an individual’s performance
measures. Multiple regression failed to
detect a relationship between age, sex, body 
weight, BMI or BSA and the personal predictive 
performance measures.
EXTENT OF CORRESPONDENCE
It is most unlikely that repeated observations on the 
same patient would give identical values for each 
variable (rmse, bias or scatter) in every individual.
I t 3 illustrates percentage of subjects
showing agreement to within selected numbers of 
units. We used zones around the lines of identity of 
approximately one-sixth of the full axis range, thus 
indicating
differed little in comparison with the total range of 
variability between patients. In spite of a total range
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of 7-29%, the repeat rmse differed by no more 
than 5% from the first for 10 of 14 patients. The 
systematic error had a wide range (—27% to +26  
%)5 whereas the difference between the first and 
repeat bias was not greater than 11%> for most 
patients. If we translate the percentage bias into 
vol% of end-expired concentration, a difference of 
less than 11% implies that the systematic errors on 
the two occasions differed by less than 0.11 vol% for 
each vol% of anaesthetic. This is a small discrepancy 
in clinical terms. It appears that individuals who 
have or have not deviated from an anticipated 
pharmacological behaviour on one occasion tend to 
behave alike on an alternate similar occasion. 
Subjects can deviate, even grossly, from the grand 
mean, yet exhibit a high level of repeatability (obser­
vations in the top right and bottom left of figure 3b) 
(left). Therefore, model-based predictions have an 
extra clinical value.
COMPONENTS OF BIOLOGICAL VARIABILITY
We estimated that, although the repeat scatters 
differed little for most patients (fig. 3), 90% of the 
total variance resulted from within-patient variance 
(table 3). As scatter varies much more from one 
anaesthetic to the next in any one patient than it does 
between the average scatter for different patients 
(fig. 3c (right)), it may be that much of this scatter is 
not caused by variation within the patient but by 
some other cause.
We estimated for rmse and bias that 75%> and
reveal if our model-based predictions can be scaled 
further between individuals by other “personal 
factors.
Our results ask the question whether we should 
save patient-related findings in a directly accessible 
“anaesthetic passport” (bearing the patient’s 
anaesthetic finger printings). This may be an aid to 
anaesthetists in the future.22 They may plan the 
anaesthetic of their patients on the basis of the 
average behaviour of a standard human, perhaps also 
according to institutional algorithms. Subsequently 
they may adapt the anaesthetic drug administration 
to tailor the anaesthetic to the physiological status of 
their patient. Models can facilitate these processes 
of decision making. But anaesthetists are also 
interested in identifying those patients who are likely 
to deviate from anticipated average behaviour. Our 
results suggest that determination of bias (or rmse) 
in a patient on one occasion, even if that bias is large, 
may be a useful predictor of bias on subsequent 
occasions. This is well illustrated in figure 3 b (left), 
apart from patient No. 12. Other authors have 
shown that the correlation of anaesthetic uptake with 
easily observable patient characteristics is poor.1823 
If the patient must receive another anaesthetic, the 
judicious use of data identified during a former 
anaesthetic may be the best basis available to adjust 
the “rules of thumb” which anaesthetists use when 
managing a patient.24
RESERVATIONS
49%, respectively, of the total variance was caused 
by between-patient variance. In contrast with 
scatter, the variance in rmse was mainly attributable 
to systematic differences between patients. For 
bias, variance was distributed evenly among its two 
components.
Comparing the results of this study with those of 
others is difficult because data on recurrent measure­
ments of inhaled anaesthetics are scarce and do not 
include estimates of both between-patient and 
within-patient but between repeat anaesthetic 
variabilities.18 20 Studies in an other area of clinical 
research also found that prediction within patients 
was easier than that between patients when using 
a physiologically based formula, and that such 
information can be useful in clinical practice.21
The data showing high repeatability were gathered 
under similar clinical conditions. Therefore, repeat­
ability values should not be extrapolated to 
apparently different conditions. Model-based drug 
regimens and algorithms are not intended as rigid 
recipes.18 They offer a reasonable approach to anaes­
thetic management that must be individualized with 
the aid of clinical observations and vigilant monitor­
ing of end-tidal concentrations and haemodynamic 
variables.25
A few patients with poor consistency and one out­
lier were found. Their presence suggests that the use 
of an adaptive model or feedback-controlled 
anaesthesia is worth considering for future develop­
ment.232627 The control algorithms needed can be 
developed initially with the aid of a model which 
should be well validated and exhibit a realistic
ASSOCIATION WITH PATIENT CHARACTERISTICS
The high within-patient consistency was a reason for 
investigating the possible association of individual 
results for rmse or bias with age, sex, body weight, 
BMI or BSA. As in previous studies, a relationship 
between individual patient characteristics and 
performance measures could not be established.2 4 
This is not surprising because these data are primary 
inputs to the model. It uses an individualized input 
to calculate some physiological variables such as 
cardiac output and functional residual capacity. The 
characteristics studied cannot be used to improve 
the model. Additional, yet unknown, factors may 
contribute in a significant extent to an individual’s 
pharmacokinetic response. Future research may
amount of variability such as that found in the 
present study.
We believe that repeatability data should 
available to each research group studying the predic­
tive performance of models, not only because it is 
important to separate within-patient from overall 
variability, but also because poor repeatability may 
highlight the need to re-examine the various 
procedures involved in gathering the data.28
In this era of multi-gas monitoring techniques and 
impending automated administration of volatile 
anaesthetics, there is still a definite role for well 
validated models of human physiology and pharma­
cology. The results for overall variability show that a 
dosing regimen based on our model is a useful 
starting strategy for administering closed-circuit
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inhalation anaesthesia; the results for within-patient 
variability suggest that a patient may benefit from 
using a starting regimen corrected from the findings 
obtained during a former anaesthetic.
Appendix 1
A concise non-mathematical account of the model is presented 
here. A comprehensive quantification and mathematical 
formulation have been presented elsewhere.1 Our physiological 
model depicts the body and closed anaesthetic circuit as a system 
of 14 compartments (fig. 4). A liquid anaesthetic agent injected 
directly into the closed system is assumed to mix uniformly after 
vaporization with the contents of the closed breathing system. 
The anaesthetic agent is taken up from the alveolar space and 
distributed to the other tissue compartments; heart, brain, 
kidneys, liver (including all other well-perfused organs), muscles, 
connective tissue and adipose tissue. The model derives from the 
subject’s age, sex, body weight and heights the other 
physiological variables, including deadspace, alveolar space, 
blood volume, cardiac output and tissue volumes.
f
PM lN IIH M W I Volatile anaesthetic agent
Closed anaesthetic system
( Alveolar space
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Pulmonary shunt
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Non-pulmonary elimination
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Figure 4 Simplified schematic diagram of the 14-compartment 
physiological model which includes the closed anaesthetic circuit 
and the patient tissues; the circles represent the blood pools 
(A.—arterial; (G.) V.=
Our system model differs from previous models for closed- 
circuit anaesthesia in four main ways. (1) Unlike the model of 
Lowe and Ernst it does not assume that the arterial 
concentration remains constant.29 This implies that the model is 
able to predict breath-by-breatii end-expired concentrations after 
bolus injections of a liquid anaesthetic agent into the closed 
system. (2) Our model does not assume that either the 
circulating times are zero or that venous blood is part of each 
tissue compartment. Rather we followed Mapleson’s suggestions 
by introducing his concept of blood pools that mimics 
circulation times in the body.30 (3) The model incorporates a 
non-pulmonary route of elimination for enflurane and
halothane.14 (4) Age-related blood-gas and tissue.blood
partition coefficients can be introduced. For halothane we 
showed that this improved the accuracy of the model.4
Appendix 2
Suppose we have p patients called i (t= l, 2, . . . ,  p) with m 
repeated observations on the same patient, giving a total of pm  
results for each of the three performance measures. If any one of
these results is y^ ( k~l ,  2, . . . ,  in), then the individual mean 
result for patient i is:
1 J2i
Vi z ,  y tkmi
The individual s d , that is a measure of the dispersion o f  the m 
repeated observations on the same subject, is given as:
,vt * • *  N *y~y¡) “
The grand mean for the sample population is:
V  1 .
p n
Three variances are calculated for each of the performance 
measures.
(1) Within-patient (or 
average of individual variances:
variance s \  is
1
, F
S ' *
W
2I
(2) Between-patient variance is an indicator of 
variation in expected means between patients; this estimate 
based on the distribution of patient means:
is
Sz
2
B
P
w
m
(3) Total sample population (or reproducibility) variance s2r  
combines within- and between-patient variances:
B
The repeatability and reproducibility SD values are given by
SDw=v^w  and sdt -  V£2t 3 respectively.
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